InflaRx (IFRX) Other Non-Current Liabilities (2016 - 2026)

InflaRx's (IFRX) quarterly Other Non-Current Liabilities came in at $33932.9 in Q1 2026, down 30.32% year-on-year from $48697.0 in Q1 2025, and down 91.88% quarter-over-quarter from $417838.1 in Q4 2025.

InflaRx (IFRX) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends

InflaRx has disclosed Other Non-Current Liabilities across 11 years of filings, most recently posting $33932.9 for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $33932.9, down 30.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $33932.9 (down 30.32% YoY), and the FY2025 annual result was $417838.1, up 960.33% from the prior year.
  • Other Non-Current Liabilities came in at $33932.9 for Q1 2026 at InflaRx, down from $417838.1 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.1 million in Q3 2023 to a low of -$2.9 million in Q2 2024.
  • The 5-year median for Other Non-Current Liabilities is $39406.6 (2024), against an average of $103777.2.
  • Across the five-year window, Other Non-Current Liabilities soared 61625.86% in 2023 and plunged 4536.37% in 2024, its largest moves.
  • InflaRx's Other Non-Current Liabilities stood at $9593.4 in 2022, then surged by 30609.7% to $2.9 million in 2023, then plunged by 98.66% to $39406.6 in 2024, then jumped by 960.33% to $417838.1 in 2025, then slumped by 91.88% to $33932.9 in 2026.
  • The last three Other Non-Current Liabilities figures came in at $33932.9 (Q1 2026), $417838.1 (Q4 2025), and $399353.9 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40

Historic Data

Download Data
DateValue
Mar 31, 2026 33,932.89
Dec 31, 2025 417,838.08
Sep 30, 2025 399,353.90
Jun 30, 2025 409,331.34
Mar 31, 2025 48,696.99
Dec 31, 2024 39,406.59
Sep 30, 2024 -2.91 Mn
Jun 30, 2024 -2.92 Mn
Mar 31, 2024 67,807.44
Dec 31, 2023 2.95 Mn
Sep 30, 2023 3.15 Mn
Jun 30, 2023 65,817.86
Mar 31, 2023 17,158.44
Dec 31, 2022 9,593.39
Sep 30, 2022 5,102.88
Jun 30, 2022 -8,396.67
Mar 31, 2022 -7,681.28
Dec 31, 2021 22,722.70
Sep 30, 2021 14,304.76
Jun 30, 2021 -8,453.99